Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
660.00    -19.00 (-2.80%)
Bid:
657.00
Ask:
660.00
Spread: 3.00 (0.457%)
Market Cap: £1.21b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Interim Management Statement

9 Feb 2010 07:00

RNS Number : 8500G
Volex Group PLC
09 February 2010
 

 

9 February 2010

 

VOLEX GROUP plc

 Interim Management Statement for the 18 weeks ended 9 February 2010

 Volex Group plc, the global electrical and electronic cable assemblies group, today releases its second Interim Management Statement for the FY2010 financial year, covering the 18 weeks ended 9 February 2010.

As indicated in the trading update released on 12 January 2010 group revenue has continued to trend upwards quarter-on-quarter, driven by strength in the consumer focused Power Products sector, which is starting to see improved OEM demand, while Interconnect remains adversely impacted by industry conditions and delayed network rollout, principally in India and China.

Favourable commodity prices and ongoing progress in the cost saving programmes has delivered further modest quarter-on-quarter improvements in gross margins, while the improvement in year-on-year gross margins is more substantial. Importantly, with initiatives underway to align the Group's manufacturing capacity and support facilities more closely with its customer base and market environment, the Group expects to be well positioned to capitalise on a more sustained economic recovery, as and when it occurs.

 Highlights for the third quarter of FY2010 (three months to 3 Jan 2010) are as follows:

·; Revenue from continuing operations of £58m, up 3% on Q2 FY2010 (down 11% on same period last year, at constant currency)

·; Gross margin of 21.4%, 1.3pts up on H1FY2010 and 6.4pts ahead of same period last year

·; Operating profit(i) from continuing operations of £3.4m, up 9% on Q2 FY2010 (up 10% on same period last year, at constant currency)

·; Net debt of £11.3m held at half year level, compared with £23.0m at the same point last year

 (i) before non-recurring items and share based payments

 

Power Products revenue in the third quarter of £37m was 5% up on Q2. Although down compared to the third quarter of last year (down 2% at constant currency), performance relative to last year is on an improving path as OEM demand improves. Much of the improvement in trading has been driven by strong sales in Asian markets as our customers continue to migrate their manufacturing capability east. Power Products gross margin in the third quarter increased to 23.4% from 21.1% in the first half due to manufacturing efficiencies and a favourable impact from commodity prices. As a result third quarter operating profit was 22% up on the second quarter and 90% up on the third quarter of last year, at constant currency.

Interconnect revenues in the third quarter were flat on Q2 and 23% down (at constant currency) on the third quarter of last year, as our telecoms customers, particularly in Europe and North America continued to face challenging market conditions with delayed network infrastructure rollouts in China and India. Trading in the Healthcare sector (approximately 30% of total Interconnect) has fared better, with Healthcare revenue in the third quarter showing a modest improvement over Q2. Although Interconnect gross margins in Q3 decreased slightly to 18.1% from 18.6% in the first half of the year, they remained well ahead of last year. 

The Group continued to manage its cash and borrowings effectively with net debt at the end of the third quarter of £11.3m in line with management's expectations, ahead of traditionally strong cash generation in the fourth quarter.

As communicated in the trading update released on 12 January 2010, the Board remains cautious on the company's short term prospects in the face of continued global economic uncertainties. However, as further noted in that announcement, the Board is comfortable that the company will meet or exceed the previous full year guidance on the trading outlook for the twelve months to 4th April 2010. 

 

- END -

 

Volex Group plc

Ray Walsh, Group Chief Executive +44 20 3370 8833 Andrew Cherry, Group Finance Director +44 20 3370 8833

 

Weber Shandwick Financial

Terry Garrett / Nick Dibden / Katie Matthews +44 20 7067 0700

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSSAFWAFSSEEE
Date   Source Headline
5th Aug 202010:28 amRNSPDMR / PCA Dealing
30th Jul 20204:29 pmRNSCompany Secretary Change
30th Jul 20204:26 pmRNSResult of AGM
30th Jul 20207:00 amRNSAGM Statement
6th Jul 20203:41 pmRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSNotice of AGM and Annual Report and Accounts
26th Jun 20203:50 pmRNSHolding(s) in Company
26th Jun 20207:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
23rd Jun 20207:00 amRNSDirector/PDMR Shareholding
22nd Jun 20206:23 pmRNSDirector/PDMR Shareholding
18th Jun 20207:01 amRNSInvestor Presentation
18th Jun 20207:00 amRNSPreliminary Group Results FY2020
1st Jun 20204:41 pmRNSSecond Price Monitoring Extn
1st Jun 20204:36 pmRNSPrice Monitoring Extension
29th Apr 20204:19 pmRNSDirector/PDMR Shareholding
24th Apr 20204:36 pmRNSPrice Monitoring Extension
20th Apr 20204:35 pmRNSPrice Monitoring Extension
16th Apr 20207:00 amRNSTrading Update
6th Apr 20204:35 pmRNSPrice Monitoring Extension
6th Apr 20201:31 pmRNSDirector/PDMR Shareholding
3rd Apr 20203:41 pmRNSDirector/PDMR Shareholding
1st Apr 20202:54 pmRNSDirector/PDMR Shareholding
30th Mar 20201:42 pmRNSDirector/PDMR Shareholding
25th Mar 20204:42 pmRNSSecond Price Monitoring Extn
25th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSChange of Registered Office
23rd Mar 20204:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20205:00 pmRNSDirector/PDMR Shareholding
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
11th Mar 20202:03 pmRNSHolding(s) in Company
9th Mar 20204:30 pmRNSDirector/PDMR Shareholding
6th Mar 20204:41 pmRNSSecond Price Monitoring Extn
6th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Mar 202012:07 pmRNSSecond Price Monitoring Extn
6th Mar 202012:02 pmRNSPrice Monitoring Extension
2nd Mar 202012:47 pmRNSDeferred Consideration for Servatron Acquisition
26th Feb 20203:49 pmRNSEBT Share Purchase
17th Feb 20207:00 amRNSStatement Regarding Situation in China - Update
13th Feb 20205:26 pmRNSEBT Share Purchase
10th Feb 20209:57 amRNSStatement Regarding Current Situation in China
15th Jan 20203:47 pmRNSHolding(s) in Company
15th Jan 20203:34 pmRNSDirector/PDMR Shareholding
6th Jan 20201:19 pmRNSHolding(s) in Company
6th Jan 20201:17 pmRNSHolding(s) in Company
20th Dec 20196:10 pmRNSHolding(s) in Company
19th Dec 20193:41 pmRNSDirector/PDMR Shareholding
18th Dec 20193:37 pmRNSHolding(s) in Company
11th Dec 20199:42 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.